B-Cell CLL/lymphoma 7A (BCL7A) Peptid
BCL7A
Wirt: Synthetic
BP, WB, IHC
Produktnummer ABIN5612307
Kurzübersicht für B-Cell CLL/lymphoma 7A (BCL7A) Peptid (ABIN5612307)
Target
BCL7A
(B-Cell CLL/lymphoma 7A (BCL7A))
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Sequenz
- QENSSNSSPA PEPNSAVPSD GTEAKVDEAQ ADGKEHPGAE DASDEQNSQS
-
Produktmerkmale
- A synthetic peptide for use as a blocking control in assays to test for specificity of BCL7A antibody, (ABIN632338)
-
-
B-Cell CLL/lymphoma 7A (BCL7A) peptide
BCL7A Reaktivität: Human, Rind (Kuh), Hund, Maus, Schwein, Ratte Wirt: Synthetic BP, Imm
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Buffer
- Lyophilized powder. Add 100 μL of distilled water for a final peptide concentration is 1 mg/mL.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 deg C long term. Avoid repeat freeze-thaw cycles.
-
-
- BCL7A (B-Cell CLL/lymphoma 7A (BCL7A))
Target
-
Sie sind hier:
